In summary, the definition of oxidative stress has evolved from a focus on ROS overproduction and cellular damage to a more nuanced understanding of the balance between oxidants and antioxidants, as well as the broader implications of redox imbalances in health and disease
If FDA later publishes a policy, the clinic should describe the scope, affected substances, pharmacy type, and conditions rather than using a blanket legality claim
In the LEAD-6 trial, overall adverse events were lower with the liraglutide group, compared with exenatide twice daily (74.9% versus 78.9%, respectively) but the severity of these effects where higher with liraglutide (serious AEs 5.1%, severe AEs 7.2%) than exenatide twice daily (serious AEs 2.6%, severe AEs 4.7%) [Buse et al
(Okay, I do need to have at least a little fun with you.) With that out in the open, lets spend a few minutes demystifying this space